TMDX Filing
4Filing Date: Mar 6, 2026
TransMedics Group, Inc. (TMDX) · Insider Trading (Form 4) SEC Filing
Statement of Changes in Beneficial Ownership
descriptionView SEC Filing
ACC: 0001193125-26-097058open_in_new
Total Value$178.5K
Trades1
Insiders1
Transaction Details
Lovell Stephanie
Director·Direct
Sell · Dispose
Common Stock
Shares-1.19K
Price$149.62
Total Value$178.5K
Shares Owned After2.87K
Transaction DateMar 4, 2026
Post-Transaction Holdings
Lovell Stephanie
| Security | Shares | Change |
|---|---|---|
| Common Stock | 2.87K | -1.19K (-29.39%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-03-04
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
--- Reporting Owner ---
Name: Lovell Stephanie
CIK: 0001772054
Role: Director
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-03-04 | Code: S (Open market sale)
Shares: -1,193 | Price: $149.62
Total Value: $178,496.66
Shares Owned After: 2,866 | Ownership: D (Direct)
--- Signature ---
/s/ By: /s/ Gerardo Hernandez, Attorney-in-Fact (2026-03-06)